Efficacy and Safety Study of Botulinum Neurotoxin A With Rehabilitation Versus Botulinum Neurotoxin A Alone in Treatment of Post-stroke Spasticity
NCT00945295 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 31
Last updated 2013-11-01
Summary
The purpose of this study is to determine if a combination of botulinum neurotoxin A and rehabilitation therapy is better than botulinum neurotoxin A alone for improvement in function based on the Fugl-Meyer and other validated measures.
Hypothesis: The combination of botulinum neurotoxin A and rehabilitation therapy will produce better functional improvement than botulinum neurotoxin A alone in post-stroke upper limb spasticity measured by the Fugl-Meyer Assessment of Sensorimotor Recovery after Stroke.
Conditions
- Upper Limb Spasticity
Interventions
- DRUG
-
Botulinum toxin type A, BoNT-A
Participants will receive IM injections of BoNT-A between 200 and 400 Units with the total dose not to exceed 6 U / kg. The primary targets for BoNT-A injection are the wrist and finger flexor muscles (flexor carpi radialis, flexor carpi ulnaris, flexor digitorum profundus, flexor digitorum superficialis).
- OTHER
-
Rehabilitation Therapy
Rehabilitation therapy
Sponsors & Collaborators
-
Allergan
collaborator INDUSTRY -
JoAnn Harnar
lead OTHER
Principal Investigators
-
Glenn D. Graham, MD, PhD · New Mexico VA Healthcare System
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-01-31
- Primary Completion
- 2012-05-31
- Completion
- 2012-05-31
Countries
- United States
Study Locations
More Related Trials
-
BOTOX® Versus Zanaflex® for the Treatment of Post-Stroke or Traumatic Brain Injury Upper Limb Spasticity
NCT00430196 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Botulinum Toxin and Recovery of Hand Function After Stroke
NCT01422161 ·Status: COMPLETED ·Phase: PHASE3
-
Safety Study of Botulinum Toxin Type A in Post-Upper Limb Stroke Patients With Reduced Lung Function
NCT00076687 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety Dose Titration Study of Botulinum Toxin Type A to Treat Spasticity in the Leg and Arm
NCT01603459 ·Status: COMPLETED ·Phase: PHASE3
-
Long-Term Study of OnabotulinumtoxinA Treatment in Adult Patients With Upper Limb Spasticity
NCT02145689 ·Status: WITHDRAWN ·Phase: PHASE3
-
Comparative Study of the Effects of Dry Needling and Botulinum Toxin Type A as a Treatment for Lower Limb Post-stroke Spasticity
NCT06296082 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
OnabotulinumtoxinA Treatment in Adult Patients With Upper Limb Spasticity
NCT02145676 ·Status: TERMINATED ·Phase: PHASE3
-
Investigating Botulinum Toxin A to Treat Acute Neck/Upper Shoulder Pain Following a New Spinal Cord Injury.
NCT00320281 ·Status: COMPLETED ·Phase: PHASE4
-
BOTOX® Treatment in Adult Patients With Post-Stroke Lower Limb Spasticity
NCT01575054 ·Status: COMPLETED ·Phase: PHASE3
-
Observational Study of Botox® Treatment for Patients With Upper Limb Adult Spasticity
NCT01387074 ·Status: COMPLETED
-
Early Use of Botulinum Toxin in Spasticity Post Stroke.
NCT01882556 ·Status: COMPLETED ·Phase: PHASE2
-
Early Treatment of Post-stroke Spasticity With Botulinum Toxin
NCT04404868 ·Status: COMPLETED
-
Trial Comparing Two Commercial Formulations of Botulinum Toxin Type A in the Treatment of Spasticity
NCT00819065 ·Status: COMPLETED ·Phase: PHASE3
-
Comparative Efficacy of Three Preparations of Botox-A in Treating Spasticity
NCT00178646 ·Status: COMPLETED ·Phase: PHASE4
-
Comparing Upper Limb Surgery and Botulinum Toxin for Spasticity: A Paired Design Study
NCT06733025 ·Status: RECRUITING ·Phase: NA
-
Phase III Study of Botulax® to Treat Post Stroke Upper Limb Spasticity
NCT01915459 ·Status: COMPLETED ·Phase: PHASE3
-
The Impact of Botox® During Robotic Rehabilitation of the Wrist Following Stroke
NCT01088230 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Prospective, Non-interventional Survey to Evaluate Injection Intervals and Treatment Modalities of Botulinum Toxin A (BoNT-A) in Adult Patients Suffering From Upper Limb Spasticity After Stroke
NCT01239628 ·Status: TERMINATED
-
Early Botulinum Toxin for Muscle Stiffness Reduction in First-Time Stroke Patients: Improving Recovery and Independence
NCT06811142 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
The Effect of Ultrasound-Guided Botulinum Toxin Injections on Pain, Functionality, Spasticity, and Range of Motion in Patients With Post-Stroke Upper Extremity Spasticity
NCT05887479 ·Status: WITHDRAWN ·Phase: PHASE4
-
Spastic Cocontractions and Limitation of Active Movements Before and After Treatment During Injection of Botulinum Toxin
NCT03453008 ·Status: UNKNOWN
-
Study of a New Generation Botulinum Toxin A2NTX to Treat Spasticity After Stroke
NCT01910363 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
BTX-A and Mirror Therapy for Chronic Stroke Spasticity
NCT07331844 ·Status: COMPLETED ·Phase: NA
-
Assessment and Management of Post-Stroke Spasticity With Botulinum Toxin-A
NCT01751373 ·Status: COMPLETED ·Phase: NA
-
Hand Rehabilitation Using Botulinum Toxin and Functional Electrical Stimulation-pilot Study
NCT03549975 ·Status: COMPLETED ·Phase: PHASE4